Novartis AG

SIX:NOVNEE

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NOVNEE's stock price target?

Price Target

131.46 CHF

According to Wall Street analysts, the average 1-year price target for NOVNEE is 131.46 CHF with a low forecast of 104.42 CHF and a high forecast of 158.09 CHF.

What is the Revenue forecast for Novartis AG?

Projected CAGR

3%

Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 3%.

What is the Gross Profit forecast for Novartis AG?

Projected CAGR

4%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 8 years is 4%.

What is the Operating Income forecast for Novartis AG?

Projected CAGR

6%

Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.

What is the Pre-Tax Income forecast for Novartis AG?

Projected CAGR

14%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 14%.

What is the Net Income forecast for Novartis AG?

Projected CAGR

7%

Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.